Growth Metrics

Boston Scientific (BSX) Total Liabilities (2016 - 2026)

Boston Scientific's Total Liabilities history spans 18 years, with the latest figure at $18.2 billion for Q1 2026.

  • On a quarterly basis, Total Liabilities rose 3.13% to $18.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $18.2 billion, a 3.13% increase, with the full-year FY2025 number at $19.2 billion, up 8.94% from a year prior.
  • Total Liabilities hit $18.2 billion in Q1 2026 for Boston Scientific, down from $19.2 billion in the prior quarter.
  • Over the last five years, Total Liabilities for BSX hit a ceiling of $37.1 billion in Q2 2024 and a floor of $12.1 billion in Q2 2022.
  • Historically, Total Liabilities has averaged $23.1 billion across 5 years, with a median of $19.1 billion in 2025.
  • Biggest five-year swings in Total Liabilities: plummeted 61.2% in 2022 and later soared 175.87% in 2023.
  • Tracing BSX's Total Liabilities over 5 years: stood at $32.2 billion in 2022, then tumbled by 51.53% to $15.6 billion in 2023, then increased by 12.94% to $17.6 billion in 2024, then grew by 8.94% to $19.2 billion in 2025, then decreased by 4.97% to $18.2 billion in 2026.
  • Business Quant data shows Total Liabilities for BSX at $18.2 billion in Q1 2026, $19.2 billion in Q4 2025, and $19.1 billion in Q3 2025.